UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Clinical potential of mass spectrometry-based proteogenomics

Nature reviews. Clinical oncology, 2019-04, Vol.16 (4), p.256-268

2019

Volltextzugriff (PDF)

An Automated and Multiplexed Method for High Throughput Peptide Immunoaffinity Enrichment and Multiple Reaction Monitoring Mass Spectrometry-based Quantification of Protein Biomarkers

Molecular & cellular proteomics, 2010-01, Vol.9 (1), p.184-196

2010

Volltextzugriff (PDF)

Effect of Collision Energy Optimization on the Measurement of Peptides by Selected Reaction Monitoring (SRM) Mass Spectrometry

Analytical chemistry (Washington), 2010-12, Vol.82 (24), p.10116-10124

2010

Volltextzugriff (PDF)

A targeted proteomics-based pipeline for verification of biomarkers in plasma

Nature biotechnology, 2011-07, Vol.29 (7), p.625-634

2011

Volltextzugriff (PDF)

Quantification of ATP7B Protein in Dried Blood Spots by Peptide Immuno-SRM as a Potential Screen for Wilson’s Disease

Journal of proteome research, 2017-02, Vol.16 (2), p.862-871

2017

Volltextzugriff (PDF)

Demonstrating the feasibility of large-scale development of standardized assays to quantify human proteins

Nature methods, 2014-02, Vol.11 (2), p.149-155

2014

Volltextzugriff (PDF)

Interlaboratory Evaluation of Automated, Multiplexed Peptide Immunoaffinity Enrichment Coupled to Multiple Reaction Monitoring Mass Spectrometry for Quantifying Proteins in Plasma

Molecular & cellular proteomics, 2012-06, Vol.11 (6), p.M111.013854-M111.013854, Article M111.013854

2012

Volltextzugriff (PDF)

Optimized Protocol for Quantitative Multiple Reaction Monitoring-Based Proteomic Analysis of Formalin-Fixed, Paraffin-Embedded Tissues

Journal of proteome research, 2016-08, Vol.15 (8), p.2717-2728

2016

Volltextzugriff (PDF)

Fanconi anemia‐isogenic head and neck cancer cell line pairs: A basic and translational science resource

International journal of cancer, 2023-07, Vol.153 (1), p.183-196

2023

Volltextzugriff (PDF)

Multiplexed Proteomic Analysis for Diagnosis and Screening of Five Primary Immunodeficiency Disorders From Dried Blood Spots

Frontiers in immunology, 2020-04, Vol.11, p.464

2020

Volltextzugriff (PDF)

Evaluation of Large Scale Quantitative Proteomic Assay Development Using Peptide Affinity-based Mass Spectrometry

Molecular & cellular proteomics, 2011-04, Vol.10 (4), p.M110.005645-M110.005645, Article M110.005645

2011

Volltextzugriff (PDF)

Immobilized Metal Affinity Chromatography Coupled to Multiple Reaction Monitoring Enables Reproducible Quantification of Phospho-signaling

Molecular & cellular proteomics, 2016-02, Vol.15 (2), p.726-739

2016

Volltextzugriff (PDF)

Rapid Multiplexed Proteomic Screening for Primary Immunodeficiency Disorders From Dried Blood Spots

Frontiers in immunology, 2018-12, Vol.9, p.2756-2756

2018

Volltextzugriff (PDF)

Anti-Peptide Monoclonal Antibodies Generated for Immuno-Multiple Reaction Monitoring-Mass Spectrometry Assays Have a High Probability of Supporting Western blot and ELISA[S]

Molecular & cellular proteomics, 2015-02, Vol.14 (2), p.382-398

2015

Volltextzugriff (PDF)

RNA and phosphoprotein profiles of TP53- and PTEN-knockouts in MCF10A at baseline and responding to DNA damage

Scientific data, 2024-01, Vol.11 (1), p.27-12, Article 27

2024

Volltextzugriff (PDF)

The interface between biomarker discovery and clinical validation: The tar pit of the protein biomarker pipeline

Proteomics. Clinical applications, 2008-10, Vol.2 (10-11), p.1386-1402

2008

Volltextzugriff (PDF)

The evolving role of mass spectrometry in cancer biomarker discovery

Cancer biology & therapy, 2009-06, Vol.8 (12), p.1083-1094

2009

Volltextzugriff (PDF)

Integrated Pipeline for Mass Spectrometry-Based Discovery and Confirmation of Biomarkers Demonstrated in a Mouse Model of Breast Cancer

Journal of proteome research, 2007-10, Vol.6 (10), p.3962-3975

2007

Volltextzugriff (PDF)

Identification of a Blood-Based Protein Biomarker Panel for Lung Cancer Detection

Cancers, 2020-06, Vol.12 (6), p.1629

2020

Volltextzugriff (PDF)

Characterization of an expanded set of assays for immunomodulatory proteins using targeted mass spectrometry

Scientific data, 2024-06, Vol.11 (1), p.682-13, Article 682

2024

Volltextzugriff (PDF)

Multiplexed quantification of estrogen receptor and HER2/Neu in tissue and cell lysates by peptide immunoaffinity enrichment mass spectrometry

Proteomics (Weinheim), 2012-04, Vol.12 (8), p.1253-1260

2012

Volltextzugriff (PDF)

Phosphoproteomic analysis of chimeric antigen receptor signaling reveals kinetic and quantitative differences that affect cell function

Science signaling, 2018-08, Vol.11 (544)

2018

Volltextzugriff (PDF)

Peptide Immunoaffinity Enrichment Coupled with Mass Spectrometry for Peptide and Protein Quantification

Clinics in laboratory medicine, 2011-09, Vol.31 (3), p.385-396

2011

Volltextzugriff (PDF)

Phase I/II results of ceralasertib as monotherapy or in combination with acalabrutinib in high-risk relapsed/refractory chronic lymphocytic leukemia

Therapeutic advances in hematology, 2023-01, Vol.14, p.20406207231173489-20406207231173489

2023

Volltextzugriff (PDF)

Targeted mass-spectrometry-based assays enable multiplex quantification of receptor tyrosine kinase, MAP kinase, and AKT signaling

Cell reports methods, 2021-07, Vol.1 (3), p.100015, Article 100015

2021

Volltextzugriff (PDF)

1 – 25 von 103

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(100)
Mit Volltextzugriff
(84)

Publikationsform

Artikel
(102)
Tagungsberichte
(1)

Sprache

Englisch
(103)
Japanisch
(27)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Clinical potential of mass spectrometry-based proteogenomics

An Automated and Multiplexed Method for High Throughput Peptide Immunoaffinity Enrichment and Multiple Reaction Monitoring Mass Spectrometry-based Quantification of Protein Biomarkers

Effect of Collision Energy Optimization on the Measurement of Peptides by Selected Reaction Monitoring (SRM) Mass Spectrometry

A targeted proteomics-based pipeline for verification of biomarkers in plasma

Quantification of ATP7B Protein in Dried Blood Spots by Peptide Immuno-SRM as a Potential Screen for Wilson’s Disease

Demonstrating the feasibility of large-scale development of standardized assays to quantify human proteins

Interlaboratory Evaluation of Automated, Multiplexed Peptide Immunoaffinity Enrichment Coupled to Multiple Reaction Monitoring Mass Spectrometry for Quantifying Proteins in Plasma

Optimized Protocol for Quantitative Multiple Reaction Monitoring-Based Proteomic Analysis of Formalin-Fixed, Paraffin-Embedded Tissues

Fanconi anemia‐isogenic head and neck cancer cell line pairs: A basic and translational science resource

Multiplexed Proteomic Analysis for Diagnosis and Screening of Five Primary Immunodeficiency Disorders From Dried Blood Spots

Evaluation of Large Scale Quantitative Proteomic Assay Development Using Peptide Affinity-based Mass Spectrometry

Immobilized Metal Affinity Chromatography Coupled to Multiple Reaction Monitoring Enables Reproducible Quantification of Phospho-signaling

Rapid Multiplexed Proteomic Screening for Primary Immunodeficiency Disorders From Dried Blood Spots

Anti-Peptide Monoclonal Antibodies Generated for Immuno-Multiple Reaction Monitoring-Mass Spectrometry Assays Have a High Probability of Supporting Western blot and ELISA[S]

RNA and phosphoprotein profiles of TP53- and PTEN-knockouts in MCF10A at baseline and responding to DNA damage

The interface between biomarker discovery and clinical validation: The tar pit of the protein biomarker pipeline

The evolving role of mass spectrometry in cancer biomarker discovery

Integrated Pipeline for Mass Spectrometry-Based Discovery and Confirmation of Biomarkers Demonstrated in a Mouse Model of Breast Cancer

Identification of a Blood-Based Protein Biomarker Panel for Lung Cancer Detection

Characterization of an expanded set of assays for immunomodulatory proteins using targeted mass spectrometry

Multiplexed quantification of estrogen receptor and HER2/Neu in tissue and cell lysates by peptide immunoaffinity enrichment mass spectrometry

Phosphoproteomic analysis of chimeric antigen receptor signaling reveals kinetic and quantitative differences that affect cell function

Peptide Immunoaffinity Enrichment Coupled with Mass Spectrometry for Peptide and Protein Quantification

Phase I/II results of ceralasertib as monotherapy or in combination with acalabrutinib in high-risk relapsed/refractory chronic lymphocytic leukemia

Targeted mass-spectrometry-based assays enable multiplex quantification of receptor tyrosine kinase, MAP kinase, and AKT signaling

Suchergebnisse filtern